Phase 1/2 Proof of Concept study investigating acalabrutinib in combination with vistusertib in subjects with Relapsed/Refractory B-cell malignancies

Type of Cancer
Lymphoma

Sponsor
Acerta

Protocol Number
ACE-LY-110

To Learn More Call
(201)-510-0950